New Hampshire 2026 Session Status: Introduced 9 R cosponsors

HB1292 — expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.

Last action — INTERIM STUDY

  1. 1
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill has been introduced in the House. Introduced December 01, 2025. It must pass committee before a floor vote.

Next likely step: a committee referral and hearing.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Not enough signal yet

Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.

Bill Text

Action History

  1. Interim Study Report: Recommended for Future Legislation 10/05/2026 (Vote 7-6; )

  2. Executive Session: 09/30/2026 10:00 am GP 230

  3. Refer for Interim Study: MA VV 03/05/2026 HJ 6 P. 24

  4. Committee Report: Refer for Interim Study 02/13/2026 (Vote 17-1; CC) HC 9 P. 18

  5. Executive Session: 02/13/2026 10:00 am GP 158

  6. Public Hearing: 02/11/2026 01:00 pm GP 230

  7. Introduced 01/07/2026 and referred to Judiciary HJ 1 P. 14

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 9 co-sponsors · 405 not signed on

Sponsors (1)

Co-sponsors (9)

Not signed on (405)

405 members have not signed on to this bill.

Show all 405 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB1292 do?
expanding the right to try act to include certain qualifying severe illness and permitting certain regenerative stem cell therapies under the act.
Who sponsors HB1292?
HB1292 is sponsored by Victoria Sullivan (Republican), Matt R Sabourin dit Choinière, Mary Murphy (Republican), Keith Murphy (Republican), Daniel Popovici-Muller (Republican), Cyril Aures (Republican), Yury Polozov (Republican), Dan McGuire (Republican), Erica Layon (Republican), and Sayra DeVito (Republican).
What is the current status of HB1292?
This bill has been introduced in the House. Introduced December 01, 2025. It must pass committee before a floor vote.
Where can I track HB1292?
Track HB1292 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB1292

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HB1292

Last checked for changes 2 days ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →